GlassScriptPhysician profile
Orin Greene
NPI 1730533589
$4,201.47
in general payments reported to CMS, 2019-2025
31 companies · $931 in 2025
The $931 reported for 2025 was more than what 79% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $978 · 2022: $730 · 2023: $760 · 2024: $804 · 2025: $931.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,345 · Education: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,344.56 |
| Education | $149.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $818.61 | 2021-2025 | Xtampza, Belbuca |
| Medtronic, INC. | $451.10 | 2021-2024 | Synchromedii, Intellis Adaptivestim, Specify Surescan Mri 5-6-5 |
| Globus Medical, INC. | $423.87 | 2025 | Senza, Vyrsa V1 |
| Fidia Pharma USA INC. | $417.21 | 2022-2025 | Hymovis, Richplat Ortho Prp System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $304.64 | 2021-2025 | Relistor |
| Scilex Pharmaceuticals INC. | $243.91 | 2021-2025 | Ztlido |
| Boston Scientific Corporation | $223.53 | 2022-2025 | Wavewriter Alpha Prime 16, Intracept Rf Probe |
| Abbvie INC. | $174.75 | 2023-2025 | |
| Relievant Medsystems, INC. | $110.00 | 2022-2023 | Intracept |
| Abbott Laboratories | $89.46 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $87.40 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $71.81 | 2023-2024 | Exparel, Iovera, Zilretta |
| Averitas Pharma INC. | $68.63 | 2023 | Qutenza |
| Hikma Pharmaceuticals USA | $66.76 | 2021-2022 | |
| Nevro Corp. | $64.26 | 2024 | Senza |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $57.47 | 2022 | |
| Tersera Therapeutics LLC | $56.23 | 2022-2024 | Prialt |
| Horizon Therapeutics Plc | $51.41 | 2021 | |
| Depuy Synthes Sales INC. | $50.85 | 2021 | |
| Redhill Biopharma INC. | $46.54 | 2021 | |
| Providence Medical Technology, INC. | $44.65 | 2021 | |
| Almatica Pharma LLC | $38.01 | 2021 | |
| Azurity Pharmaceuticals, INC. | $37.20 | 2023 | Horizant |
| Pfizer INC. | $33.01 | 2023 | |
| Arbor Pharmaceuticals, INC. | $32.13 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $29.73 | 2021 | |
| Biodelivery Sciences International, INC. | $27.62 | 2021 | |
| Pacira Therapeutics, INC. | $24.50 | 2021 | |
| Spinal Simplicity, LLC | $23.25 | 2025 | Ha Minuteman G3-R |
| Foundation Fusion Solutions, LLC | $16.56 | 2024 | |
| Bioventus LLC | $16.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Orin Greene listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.